AcquisitionsJun 2, 2026, 06:12 AM
Hims & Hers Completes Acquisition of Eucalyptus
AI Summary
Hims & Hers Health, Inc. announced the completion of its acquisition of Eucalyptus, a move expected to solidify its position as the world's largest consumer health platform. This strategic acquisition expands Hims & Hers' global reach across key markets including the US, UK, Australia, and Canada, with further expansion into Europe and Japan. The company reiterated its long-term financial targets of $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA by 2030. Concurrently, Hims & Hers amended its revolving credit agreement to facilitate the acquisition, which involved changes to covenants and investment capacity.
Key Highlights
- Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus.
- The acquisition aims to advance Hims & Hers' position as the world's largest consumer health platform.
- The combined entity will have a leading presence across the US, UK, Australian, and Canadian markets, with growing presence in France, Germany, Ireland, Spain, and Japan.
- Hims & Hers reaffirms long-term targets of $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA by 2030.
- Eucalyptus has served over 850,000 customers as of May 2026.
- Amendment No. 3 to the Revolving Credit and Guaranty Agreement was entered into on May 29, 2026, to facilitate the acquisition.
Price Impact
More from HIMS